In-Office Treatment vs Home Remedies

People with dry eye disease understandably want to manage it at home, and home measures matter. But there is a meaningful difference between what self-care can achieve and what professional, in-office treatment can deliver, and the best outcomes usually come from combining the two.

What home remedies can do

At-home care, warm compresses, lid hygiene, artificial tears, screen habits and a healthy environment, helps control symptoms and supports the ocular surface day to day. Its strengths are accessibility and continuity. Its weaknesses are that it depends on sustained daily effort, it manages symptoms more than drivers, and consumer warm masks and gadgets are not regulated medical devices and make no validated claim. See why medical-grade matters.

What in-office treatment adds

Professional treatment begins with something home care cannot provide: an accurate diagnosis that identifies the specific drivers. It then applies regulated medical devices at controlled, validated doses under clinical oversight. LM™ LLLT photobiomodulation and, where appropriate, OPE™ IPL on eye-light® act on the underlying inflammation and gland dysfunction in a way that compresses and drops do not, with an evidence base recognised in TFOS DEWS III (2025, American Journal of Ophthalmology).

The role of validated home therapy

There is also a middle path. my-mask® is a regulated, home-use medical device, a simplified single dry eye treatment that an eye care professional can recommend for between-visit maintenance. It differs fundamentally from an unregulated consumer gadget because it is a cleared Class II device used within a professional plan.

How they work together

The most effective approach is layered: professional diagnosis and in-office treatment to address the drivers, supported by home care, and where appropriate validated home therapy, to maintain the benefit. Home measures are the foundation; professional treatment is what acts on the cause. The plan is set with an eye care professional. For patients, see the dry eye guide.

Not all solutions and indications are cleared in all countries and for all cohorts. Every piece of information ought to be considered as fact-based evidence deriving from publicly available literature, for the sole purpose of scientific exchange.